Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

α-Tocopheryl acetate is well absorbed through healthy skin.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

A specific gene mutation causes vitamin D-resistant rickets and hair loss.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Reflectance confocal microscopy helped tell periorificial dermatitis apart from similar skin conditions.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Ruxolitinib cream may help treat severe hair loss in children.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Vitamin D3 and its receptor help protect skin from UVB-related cancer.

Strong steroid cream works better than tretinoin cream for patchy scalp hair loss.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Vitamin A affects the resting phase of hair growth, with both low and high levels increasing the number of hair follicles in this phase.

The combination therapy was effective and well-tolerated, especially in young patients.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

Retinoic acid affects hair growth and can cause hair loss.

KRT14 gene variants cause dermatopathia pigmentosa reticularis, affecting nails, teeth, and hair.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.